ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nicolas Mounier Emmanuel Bachy René-Olivier Casasnovas |
| Publication date | May 14, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |